TORRENT PHARMACEUTICALS
|
TORRENT PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹15,211 Cr | ₹14,878 Cr | ₹14,953 Cr | ₹14,527 Cr | ₹11,256 Cr |
Sales | ₹15,122 Cr | ₹14,760 Cr | ₹14,794 Cr | ₹14,316 Cr | ₹11,131 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹89 Cr | ₹118 Cr | ₹159 Cr | ₹211 Cr | ₹125 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr | ₹7,673 Cr | ₹5,950 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹74 Cr | ₹-279 Cr | ₹-133 Cr | ₹83 Cr | ₹-362 Cr |
Raw Material Consumed | ₹2,157 Cr | ₹2,239 Cr | ₹2,115 Cr | ₹1,958 Cr | ₹1,897 Cr |
Opening Raw Materials | ₹985 Cr | ₹741 Cr | ₹664 Cr | ₹604 Cr | ₹567 Cr |
Purchases Raw Materials | ₹1,182 Cr | ₹1,478 Cr | ₹1,270 Cr | ₹1,171 Cr | ₹938 Cr |
Closing Raw Materials | ₹841 Cr | ₹985 Cr | ₹741 Cr | ₹664 Cr | ₹604 Cr |
Other Direct Purchases / Brought in cost | ₹831 Cr | ₹1,005 Cr | ₹923 Cr | ₹846 Cr | ₹997 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹144 Cr | ₹123 Cr | ₹128 Cr | ₹132 Cr | ₹119 Cr |
Electricity & Power | ₹144 Cr | ₹123 Cr | ₹128 Cr | ₹132 Cr | ₹119 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,526 Cr | ₹1,440 Cr | ₹1,429 Cr | ₹1,404 Cr | ₹1,135 Cr |
Salaries, Wages & Bonus | ₹1,305 Cr | ₹1,245 Cr | ₹1,233 Cr | ₹1,208 Cr | ₹967 Cr |
Contributions to EPF & Pension Funds | ₹134 Cr | ₹118 Cr | ₹123 Cr | ₹124 Cr | ₹108 Cr |
Workmen and Staff Welfare Expenses | ₹60 Cr | ₹49 Cr | ₹51 Cr | ₹49 Cr | ₹40 Cr |
Other Employees Cost | ₹28 Cr | ₹26 Cr | ₹22 Cr | ₹22 Cr | ₹20 Cr |
Other Manufacturing Expenses | ₹591 Cr | ₹551 Cr | ₹544 Cr | ₹559 Cr | ₹458 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹88 Cr | ₹75 Cr | ₹51 Cr | ₹58 Cr | ₹48 Cr |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | ₹211 Cr | ₹186 Cr | ₹185 Cr | ₹178 Cr | ₹138 Cr |
Other Mfg Exp | ₹292 Cr | ₹290 Cr | ₹308 Cr | ₹322 Cr | ₹272 Cr |
General and Administration Expenses | ₹638 Cr | ₹633 Cr | ₹802 Cr | ₹764 Cr | ₹678 Cr |
Rent , Rates & Taxes | - | - | - | - | - |
Insurance | - | - | - | - | - |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹111 Cr | ₹140 Cr | ₹88 Cr | ₹137 Cr | ₹138 Cr |
Traveling and conveyance | ₹82 Cr | ₹62 Cr | ₹108 Cr | ₹129 Cr | ₹103 Cr |
Other Administration | ₹527 Cr | ₹494 Cr | ₹714 Cr | ₹627 Cr | ₹540 Cr |
Selling and Distribution Expenses | ₹885 Cr | ₹743 Cr | ₹807 Cr | ₹738 Cr | ₹641 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹885 Cr | ₹743 Cr | ₹807 Cr | ₹738 Cr | ₹641 Cr |
Miscellaneous Expenses | ₹62 Cr | ₹75 Cr | ₹76 Cr | ₹58 Cr | ₹43 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | ₹0.90 Cr | ₹14 Cr | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | - | - | - | ₹1.09 Cr | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹61 Cr | ₹60 Cr | ₹76 Cr | ₹57 Cr | ₹43 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr | ₹5,696 Cr | ₹4,609 Cr |
Operating Profit (Excl OI) | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr | ₹1,976 Cr | ₹1,341 Cr |
Other Income | ₹197 Cr | ₹57 Cr | ₹121 Cr | ₹64 Cr | ₹307 Cr |
Interest Received | ₹7.15 Cr | ₹5.07 Cr | ₹7.96 Cr | ₹16 Cr | ₹6.66 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | ₹9.88 Cr | ₹16 Cr | ₹29 Cr | ₹39 Cr | ₹53 Cr |
Provision Written Back | - | - | - | ₹5.48 Cr | ₹8.20 Cr |
Foreign Exchange Gains | ₹170 Cr | ₹32 Cr | ₹83 Cr | - | ₹237 Cr |
Others | ₹9.99 Cr | ₹4.37 Cr | ₹1.40 Cr | ₹2.46 Cr | ₹2.23 Cr |
Operating Profit | ₹2,628 Cr | ₹2,537 Cr | ₹2,292 Cr | ₹2,040 Cr | ₹1,648 Cr |
Interest | ₹255 Cr | ₹353 Cr | ₹451 Cr | ₹504 Cr | ₹308 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹2.13 Cr | ₹2.12 Cr | ₹2.35 Cr | ₹2.65 Cr | ₹3.69 Cr |
Other Interest | ₹253 Cr | ₹351 Cr | ₹448 Cr | ₹501 Cr | ₹305 Cr |
PBDT | ₹2,373 Cr | ₹2,184 Cr | ₹1,841 Cr | ₹1,536 Cr | ₹1,340 Cr |
Depreciation | ₹662 Cr | ₹658 Cr | ₹654 Cr | ₹618 Cr | ₹409 Cr |
Profit Before Taxation & Exceptional Items | ₹1,711 Cr | ₹1,526 Cr | ₹1,187 Cr | ₹919 Cr | ₹931 Cr |
Exceptional Income / Expenses | ₹-485 Cr | - | - | ₹-357 Cr | - |
Profit Before Tax | ₹1,226 Cr | ₹1,526 Cr | ₹1,187 Cr | ₹562 Cr | ₹931 Cr |
Provision for Tax | ₹449 Cr | ₹274 Cr | ₹162 Cr | ₹125 Cr | ₹253 Cr |
Current Income Tax | ₹346 Cr | ₹334 Cr | ₹260 Cr | ₹279 Cr | ₹199 Cr |
Deferred Tax | ₹107 Cr | ₹-53 Cr | ₹-59 Cr | ₹-155 Cr | ₹-8.56 Cr |
Other taxes | ₹-4.02 Cr | ₹-6.72 Cr | ₹-39 Cr | ₹1.34 Cr | ₹62 Cr |
Profit After Tax | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr | ₹436 Cr | ₹678 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | ₹-0.03 Cr | ₹-0.03 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr | ₹436 Cr | ₹678 Cr |
Adjustments to PAT | - | - | - | - | ₹1.32 Cr |
Profit Balance B/F | ₹2,806 Cr | ₹1,893 Cr | ₹1,616 Cr | ₹1,554 Cr | ₹1,514 Cr |
Appropriations | ₹3,584 Cr | ₹3,145 Cr | ₹2,641 Cr | ₹1,990 Cr | ₹2,194 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | ₹125 Cr | ₹63 Cr | ₹45 Cr |
Other Appropriation | ₹244 Cr | ₹-0.04 Cr | ₹81 Cr | ₹91 Cr | ₹443 Cr |
Equity Dividend % | ₹960.00 | ₹700.00 | ₹640.00 | ₹340.00 | ₹280.00 |
Earnings Per Share | ₹45.92 | ₹73.97 | ₹60.55 | ₹25.78 | ₹40.07 |
Adjusted EPS | ₹22.96 | ₹36.99 | ₹30.27 | ₹12.89 | ₹20.03 |
Compare Income Statement of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹91,112.5 Cr | 6.1% | 5.3% | 66.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,831.0 Cr | -0.1% | -2.8% | 50.3% | Stock Analytics | |
CIPLA | ₹113,471.0 Cr | 4.5% | -3.1% | 52.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,713.0 Cr | 4.6% | 1.4% | 22.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,960.0 Cr | 4.7% | 10.8% | 18.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,687.8 Cr | 3.1% | -4.1% | 80.4% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 6.1% |
5.3% |
66.2% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses